HOME >> BIOLOGY >> NEWS
University of Toronto professor finds key protein in fight against plant disease

A University of Toronto botanist has identified a protein that ultimately could provide chemical-free ways to protect crops from disease.

"Finding this protein, called DIR1, could help make it possible to genetically engineer crops that resist disease-causing organisms," says Robin Cameron, a professor of botany at U of T and the senior investigator of the study, which appears in the Sept. 26 issue of Nature. "In the long run, having a better understanding of the whole process of disease resistance in plants could eliminate the need for fungicides or bacteriocides."

When disease strikes a plant, its immune system sends up a warning "flare" telling different areas of the plant to resist infection. "This process is kind of like vaccination, only better," Cameron says. Once the signal-dependant on DIR1-is triggered by one disease, it gives the plant systemic acquired resistance (SAR) to many other diseases. The exact role of DIR1 in the signal process is not yet clear, she says.

Cameron, along with colleagues at the Salk Institute in La Jolla, Calif., the John Innes Centre in Norwich, U.K. and the Noble Foundation in Ardmore, Okla., studied a mutant strain of weed with abnormal DIR1 that does not develop SAR when exposed to a certain bacterial disease. "Our studies indicate that the normal protein, DIR1, is required to either make or move the warning signal around the plant," she says.


'"/>

Contact: Nicolle Wahl
nicolle.wahl@utoronto.ca
416-978-6974
University of Toronto
25-Sep-2002


Page: 1

Related biology news :

1. Indiana University, EPA to study airborne PCBs
2. University of Alberta researcher looks for clues to mysterious disease
3. Northeastern University receives $12.4 million NSF grant for creation of nanomanufacturing institute
4. Washington University in St. Louis leads group studying aging process
5. Tufts University establishes $4 million dollar tissue engineering resource center
6. Case for IBD combination therapy comes from research at Baylor, MIT and Hebrew University
7. As informatics grows, Indiana University helps set research agenda
8. University of Arizona licenses patent for natural fungicide
9. Washington University in St. Louis plays key role in sequencing moss genome
10. University of Pittsburgh receives $10 million grant for head and neck cancer
11. Clemson University spin-off uses corn to make plastics, provide cleaner air

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:4/6/2017)... Forecasts by Product Type (EAC), ... End-Use (Transportation & Logistics, Government & Public Sector, Utilities ... Generation Facility, Nuclear Power), Industrial, Retail, Business Organisation (BFSI), ... you looking for a definitive report on the $27.9bn ... ...
(Date:4/5/2017)... April 4, 2017 KEY FINDINGS ... expand at a CAGR of 25.76% during the forecast ... the primary factor for the growth of the stem ... https://www.reportbuyer.com/product/4807905/ MARKET INSIGHTS The global stem cell ... application, and geography. The stem cell market of the ...
(Date:3/30/2017)... , March 30, 2017  On April 6-7, ... Hack the Genome hackathon at Microsoft,s headquarters ... two-day competition will focus on developing health and wellness ... Hack the Genome is the first ... tremendous. The world,s largest companies in the genomics, tech ...
Breaking Biology News(10 mins):
(Date:10/12/2017)... ... October 12, 2017 , ... ... multicenter, prospective clinical study that demonstrates the accuracy of the FebriDx® test, ... clinically significant acute bacterial and viral respiratory tract infections by testing the ...
(Date:10/11/2017)... YORBA LINDA, CA (PRWEB) , ... October 11, ... ... adapted to upregulate any gene in its endogenous context, enabling overexpression experiments and ... activation (CRISPRa) system with small RNA guides is transformative for performing systematic gain-of-function ...
(Date:10/11/2017)... and LAGUNA HILLS, Calif. , Oct. ... Cancer Research, London (ICR) and University ... SKY92, SkylineDx,s prognostic tool to risk-stratify patients with multiple myeloma ... MUK nine . The University of Leeds ... partly funded by Myeloma UK, and ICR will perform the ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... advancing targeted antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give ... Liposomal Nanoparticle), a technology developed in collaboration with Children’s Hospital Los Angeles ...
Breaking Biology Technology:
Cached News: